Literature DB >> 2700375

Mechanisms of postischemic vascular dysfunction in skeletal muscle: implications for therapeutic intervention.

D L Carden1, R J Korthuis.   

Abstract

In 1981, it was first proposed that xanthine oxidase-derived reactive oxygen metabolites contribute to the microvascular and parenchymal cell damage which occurs when ischemic tissues are reperfused. Figure 1 summarizes a scheme that has been proposed to explain the interaction of xanthine oxidase-derived oxidants, neutrophil infiltration, and the microvascular dysfunction which occurs in postischemic tissue. According to this proposal, xanthine oxidase-derived oxidants, produced at the time of reperfusion, initiate the formation and release of proinflammatory agents, which subsequently attract and activate neutrophils. The activated granulocytes adhere to vascular endothelium, extravasate, and release cytotoxic oxidants and/or non-oxidative toxins (e.g. proteases) which contribute to tissue destruction. The objective of this review is to summarize the supportive evidence for this scheme in postischemic skeletal muscle and to identify the components of the mechanism that may be amenable to pharmacologic intervention.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2700375

Source DB:  PubMed          Journal:  Microcirc Endothelium Lymphatics        ISSN: 0740-9451


  3 in total

Review 1.  Inflammatory responses to ischemia and reperfusion in skeletal muscle.

Authors:  D C Gute; T Ishida; K Yarimizu; R J Korthuis
Journal:  Mol Cell Biochem       Date:  1998-02       Impact factor: 3.396

Review 2.  Resolution of Inflammation after Skeletal Muscle Ischemia-Reperfusion Injury: A Focus on the Lipid Mediators Lipoxins, Resolvins, Protectins and Maresins.

Authors:  Cindy Barnig; Gaetan Lutzweiler; Margherita Giannini; Anne Lejay; Anne-Laure Charles; Alain Meyer; Bernard Geny
Journal:  Antioxidants (Basel)       Date:  2022-06-20

3.  Expression of a muscle-specific, nitric oxide synthase transgene prevents muscle membrane injury and reduces muscle inflammation during modified muscle use in mice.

Authors:  Hal X Nguyen; James G Tidball
Journal:  J Physiol       Date:  2003-05-23       Impact factor: 5.182

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.